Oncimmune seals US sales agreement with Biodesix
Immunodiagnostics group Oncimmune said it had completed a strategic commercialisation agreement with Biodesix.
The pact involved the company's arlyCDT Lung cancer detection technology for use...
Fri, 01/11/2019 - 07:41